{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:37:46Z","timestamp":1786991866446,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Raymond Kwok Family Research Fund"},{"name":"Andreas Dracopoulos Research fund"},{"name":"George and Lavinia Blick Research Fund"},{"name":"Eye Bank Association of America\/Richard Lindstrom Research"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY027827"],"award-info":[{"award-number":["R01EY027827"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30-EY001765"],"award-info":[{"award-number":["P30-EY001765"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG3DA048768"],"award-info":[{"award-number":["UG3DA048768"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FDA","award":["HHSF223201810114C"],"award-info":[{"award-number":["HHSF223201810114C"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jconrel.2020.08.019","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T02:22:50Z","timestamp":1597717370000},"page":"456-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Sunitinib malate-loaded biodegradable microspheres for the prevention of corneal neovascularization in rats"],"prefix":"10.1016","volume":"327","author":[{"given":"Jin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9728-2643","authenticated-orcid":false,"given":"Guihong","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Emmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Eberhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seulki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter J.","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Ensign","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Hanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3191-0771","authenticated-orcid":false,"given":"Qingguo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.08.019_bb0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0010","series-title":"Ocular Angiogenesis: Diseases, Mechanisms, and Therapeutics in","first-page":"45","author":"Carmichael","year":"2006"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease","volume":"1","author":"Folkman","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0025","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-cellbio-092910-154002","article-title":"Developmental and pathological angiogenesis","volume":"27","author":"Chung","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1542-0124(11)70035-0","article-title":"Anti-VEGF treatment of corneal neovascularization","volume":"9","author":"Keating","year":"2011","journal-title":"Ocul Surf."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0035","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization","volume":"39","author":"Amano","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/exer.1999.0790","article-title":"Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization","volume":"70","author":"Kvanta","year":"2000","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0045","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/bjo.2006.107417","article-title":"Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier","volume":"91","author":"Ambati","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0050","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.0506112103","article-title":"Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision","volume":"103","author":"Cursiefen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0055","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1172\/JCI200318549","article-title":"Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors","volume":"112","author":"Abramsson","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0060","first-page":"4821","article-title":"Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C","volume":"52","author":"Finkenzeller","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0065","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1158\/1078-0432.CCR-07-1893","article-title":"Combination of vascular endothelial growth factor receptor\/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy","volume":"14","author":"Timke","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0070","doi-asserted-by":"crossref","first-page":"462","DOI":"10.2174\/156800910791517208","article-title":"Tyrosine kinase inhibitors","volume":"10","author":"Natoli","year":"2010","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0075","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/ICO.0b013e31823f8b9c","article-title":"Inhibition of corneal neovascularization in rats by systemic administration of sorafenib","volume":"31","author":"Seo","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0080","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ajo.2010.04.024","article-title":"Inhibition of corneal neovascularization by topical bevacizumab (anti-VEGF) and sunitinib (anti-VEGF and anti-PDGF) in an animal model","volume":"150","author":"P\u00e9rez-Santonja","year":"2010","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0085","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/ICO.0b013e3182801645","article-title":"Inhibition of corneal neovascularization by subconjunctival and topical bevacizumab and sunitinib in a rabbit model","volume":"32","author":"Ko","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0090","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1167\/iovs.07-1314","article-title":"Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation","volume":"49","author":"Hos","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0095","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1167\/iovs.12-11032","article-title":"Safety and efficacy of the multitargeted receptor kinase inhibitor Pazopanib in the treatment of corneal neovascularization","volume":"54","author":"Amparo","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0100","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1167\/iovs.12-10856","article-title":"Sunitinib inhibits inflammatory corneal Lymphangiogenesis","volume":"54","author":"Detry","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0105","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/nn506599f","article-title":"Ocular drug delivery Nanowafer with enhanced therapeutic efficacy","volume":"9","author":"Yuan","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0110","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.exer.2010.02.014","article-title":"Membrane-tethered mucins have multiple functions on the ocular surface","volume":"90","author":"Govindarajan","year":"2010","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0115","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s11095-008-9694-0","article-title":"Recent perspectives in ocular drug delivery","volume":"26","author":"Gaudana","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0120","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.survophthal.2008.08.002","article-title":"Adherence and persistence with glaucoma therapy","volume":"53","author":"Schwartz","year":"2008","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0125","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0002-9394(99)00129-4","article-title":"High concentration of dexamethasone in aqueous and vitreous after subconjunctival injection","volume":"128","author":"Weijtens","year":"1999","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2015.01.009","article-title":"Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats","volume":"201","author":"Pan","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0135","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0140","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1124\/dmd.110.037408","article-title":"Influence of drug solubility and lipophilicity on transscleral retinal delivery of six corticosteroids","volume":"39","author":"Thakur","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0145","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2019.01.018","article-title":"Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis","volume":"296","author":"Luo","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0150","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1167\/iovs.12-10583","article-title":"The effect of rho-associated kinase inhibition on the ocular penetration of timolol maleate","volume":"54","author":"Arnold","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0155","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1167\/iovs.11-8499","article-title":"Anti-angiogenic effect of KR-31831 on corneal and choroidal neovascularization in rat models","volume":"53","author":"Kim","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nano.2019.01.001","article-title":"Controlled release of dexamethasone sodium phosphate with biodegradable nanoparticles for preventing experimental corneal neovascularization","volume":"17","author":"Wang","year":"2019","journal-title":"Nanomedicine: NBM"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0165","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","article-title":"Current and emerging therapies for corneal neovascularization","volume":"16","author":"Roshandel","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1089\/jop.2006.22.213","article-title":"A novel vascular endothelial growth factor receptor 2 inhibitor, SU11248, suppresses choroidal neovascularization in vivo","volume":"22","author":"Takahashi","year":"2006","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0175","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1080\/02713680802492440","article-title":"Identification of a novel vascular endothelial growth factor receptor 2 inhibitor and its effect for choroidal neovascularization in vivo","volume":"33","author":"Takahashi","year":"2008","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0180","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/02713680903429007","article-title":"Effect of subconjunctival and intraocular bevacizumab injections on corneal neovascularization in a mouse model","volume":"35","author":"Avisar","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0185","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","article-title":"Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label noncomparative study","volume":"127","author":"Dastjerdi","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0190","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2353\/ajpath.2006.050588","article-title":"Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization","volume":"168","author":"Jo","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0195","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/02713683.2011.652286","article-title":"Advances in ocular drug delivery","volume":"37","author":"Rawas-Qalaji","year":"2012","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0200","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/ICU.0b013e328330ccb9","article-title":"Recent advances in drug delivery systems for treating ocular complications of systemic diseases","volume":"20","author":"Lee","year":"2009","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0205","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/S0161-6420(02)01176-4","article-title":"Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate","volume":"109","author":"Weijtens","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0210","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1136\/bjo.2008.154906","article-title":"Penetration of topical and subconjunctival corticosteroids into human aqueous humour and its therapeutic significance","volume":"93","author":"Awan","year":"2009","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0215","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0220","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0225","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1211\/jpp.57.12.0005","article-title":"Size-dependent disposition of nanoparticles and microparticles following subconjunctival administration","volume":"57","author":"Amrite","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2005.07.009","article-title":"Plasticizing effect of water on poly(lactide-co-glycolide)","volume":"108","author":"Blasi","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-14340-x","article-title":"Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles","volume":"11","author":"Tsujinaka","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0240","unstructured":"J. Fu, J. Hanes, J. Kays, Y. Yu, M. Yang, J. Cleland, W. Stark, Q. Xu, J. Yang, Sunitinib formulations and methods for use thereof in treatment of ocular disorders, Patent application WO2016100392A1. June 23, 2016, in."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0245","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2017.09.029","article-title":"Tolerance of high and low amounts of PLGA microspheres loaded with mineralocorticoid receptor antagonist in retinal target site","volume":"266","author":"Zhao","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0250","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/CS20040370","article-title":"The vascular endothelial growth factor (VEGF)\/VEGF receptor system and its role under physiological and pathological conditions","volume":"109","author":"Takahashi","year":"2005","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0255","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.277.5323.242","article-title":"Pericyte loss and microaneurysm formation in PDGF-B-deficient mice","volume":"277","author":"Lindahl","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0260","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1242\/dev.126.14.3047","article-title":"Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse","volume":"126","author":"Hellstrom","year":"1999","journal-title":"Development"},{"key":"10.1016\/j.jconrel.2020.08.019_bb0265","first-page":"327","article-title":"In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic\/pharmacodynamic relationship","volume":"9","author":"Mendel","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0270","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1582-4934.2005.tb00355.x","article-title":"Matrix metalloproteinases and angiogenesis","volume":"9","author":"Rundhaug","year":"2005","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2020.08.019_bb0275","first-page":"1163","article-title":"Celastrol nanoparticles inhibit corneal neovascularization induced by suturing in rats","volume":"7","author":"Li","year":"2012","journal-title":"Int. J. Nanomedicine"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920304594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920304594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T23:11:11Z","timestamp":1718406671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920304594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":55,"alternative-id":["S0168365920304594"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.019","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sunitinib malate-loaded biodegradable microspheres for the prevention of corneal neovascularization in rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}